1-161509873-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001136219.3(FCGR2A):āc.418A>Gā(p.Met140Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000841 in 1,614,220 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001136219.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00133 AC: 203AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000823 AC: 207AN: 251482Hom.: 1 AF XY: 0.000736 AC XY: 100AN XY: 135916
GnomAD4 exome AF: 0.000789 AC: 1153AN: 1461874Hom.: 1 Cov.: 32 AF XY: 0.000765 AC XY: 556AN XY: 727238
GnomAD4 genome AF: 0.00135 AC: 205AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.00114 AC XY: 85AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | FCGR2A: BS1 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at